Table 3. Thromboelastography parameters of patients receiving various maintenance fluids.
Parameter/time | Group RL | Group HES | Group JEL |
---|---|---|---|
R (min) | |||
t1 | 5.79 ± 1.34* | 4.23 ± 0.8* | 5.08 ± 1* |
t2 | 3.46 ± 1.95# | 4.85 ± 1.52 | 5.33 ± 1.18 |
t3 | 4.11 ± 1.8 | 4.75 ± 1.49 | 5.62 ± 1.16 |
K (min) | |||
t1 | 1.96 ± 0.66* | 1.44 ± 0.38* | 1.64 ± 0.32 |
t2 | 1.25 ± 0.58# | 1.93 ± 0.58 | 1.87 ± 0.78 |
t3 | 1.71 ± 0.64 | 2.24 ± 1.21 | 1.97 ± 0.91 |
α angle | |||
t1 | 64.86 ± 7.47* | 65.04 ± 4.84* | 69.47 ± 6.94 |
t2 | 76.20 ± 7.28# | 62.14 ± 6.32 | 67.79 ± 4.71 |
t3 | 70.54 ± 7.73 | 60.55 ± 8.14 | 67.84 ± 4.83 |
MA (mm) | |||
t1 | 59.82 ± 4.71* | 63.02 ± 5.68* | 64.35 ± 6.41 |
t2 | 67.08 ± 5.77 | 60.32 ± 4.96 | 63.03 ± 6.24 |
t3 | 65.86 ± 4.58 | 60.90 ± 6.19 | 62.83 ± 7.15 |
Data are reported as means ± SD for 25 patients/group. RL = Ringer's lactate; HES = 6% hydroxyethyl starch (130/0.4); JEL = 4% succinylated gelatin; R = reaction time; K = coagulation time; MA = maximum amplitude; t1 = baseline; t2 = at the end of surgery; t3 = 24 h after surgery.
P < 0.05, compared to other times within groups;
P < 0.05, compared to t3 within groups (paired sample t-test).